DK1196433T3 - Cyclic peptide derivatives as inhibitors of the alpha v, beta-6 integrin - Google Patents
Cyclic peptide derivatives as inhibitors of the alpha v, beta-6 integrinInfo
- Publication number
- DK1196433T3 DK1196433T3 DK00943971T DK00943971T DK1196433T3 DK 1196433 T3 DK1196433 T3 DK 1196433T3 DK 00943971 T DK00943971 T DK 00943971T DK 00943971 T DK00943971 T DK 00943971T DK 1196433 T3 DK1196433 T3 DK 1196433T3
- Authority
- DK
- Denmark
- Prior art keywords
- integrin
- inhibitors
- beta
- alpha
- cyclic peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19933173A DE19933173A1 (en) | 1999-07-15 | 1999-07-15 | Cyclic peptide derivatives as inhibitors of the integrin alpha¶v¶beta¶6¶ |
| PCT/EP2000/006188 WO2001005810A2 (en) | 1999-07-15 | 2000-07-03 | CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN αVβ¿6? |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1196433T3 true DK1196433T3 (en) | 2007-02-12 |
Family
ID=7914891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00943971T DK1196433T3 (en) | 1999-07-15 | 2000-07-03 | Cyclic peptide derivatives as inhibitors of the alpha v, beta-6 integrin |
Country Status (23)
| Country | Link |
|---|---|
| EP (2) | EP1754714A1 (en) |
| JP (1) | JP2003505395A (en) |
| KR (1) | KR20020010928A (en) |
| CN (1) | CN1361792A (en) |
| AR (1) | AR024742A1 (en) |
| AT (1) | ATE340803T1 (en) |
| AU (1) | AU772782C (en) |
| BR (1) | BR0012418A (en) |
| CA (1) | CA2379022A1 (en) |
| CZ (1) | CZ200226A3 (en) |
| DE (2) | DE19933173A1 (en) |
| DK (1) | DK1196433T3 (en) |
| ES (1) | ES2273703T3 (en) |
| HK (1) | HK1048641A1 (en) |
| HU (1) | HUP0201925A3 (en) |
| MX (1) | MXPA02000465A (en) |
| NO (1) | NO20020176D0 (en) |
| PL (1) | PL354363A1 (en) |
| PT (1) | PT1196433E (en) |
| SK (1) | SK262002A3 (en) |
| TW (1) | TWI226890B (en) |
| WO (1) | WO2001005810A2 (en) |
| ZA (1) | ZA200201275B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2438663C (en) * | 2001-02-19 | 2009-09-15 | Takara Bio Inc. | Cyclic peptide |
| DE10118550A1 (en) * | 2001-04-14 | 2002-10-17 | Merck Patent Gmbh | New 3-ethanoylamino-3-phenyl-propionic acid derivatives, are integrin agonists or antagonists useful e.g. for treating angiogenic, cardiovascular, inflammatory, osteolytic or tumor diseases or infections |
| JP4912881B2 (en) * | 2003-10-01 | 2012-04-11 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Αvβ3 and αvβ6 integrin antagonists as antifibrotic agents |
| AU2004297202B2 (en) * | 2003-12-03 | 2011-08-25 | The Scripps Research Institute | Integrin alphaIIbbeta3 specific antibodies and peptides |
| JP2008515886A (en) | 2004-10-06 | 2008-05-15 | エーエムアール テクノロジー インコーポレイテッド | Cyclosporine alkynes and their usefulness as medical drugs |
| GB0520068D0 (en) * | 2005-10-03 | 2005-11-09 | Cancer Res Technology | av peptide ligand |
| US7696165B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
| US7696166B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
| RU2009107277A (en) | 2006-08-03 | 2010-09-10 | Астразенека Аб (Se) | ANTIBODIES AIMED AT αVβ6 AND THEIR APPLICATION |
| EP2784511A1 (en) | 2013-03-27 | 2014-10-01 | Universität Zürich | Integrin alpha-v-beta6 for diagnosis/prognosis of colorectal carcinoma |
| SI3350222T1 (en) * | 2015-09-18 | 2022-01-31 | Technische Universitaet Muenchen | Ligands for integrin avbeta6, synthesis and uses thereof |
| CA3054604A1 (en) | 2017-02-28 | 2018-09-07 | Morphic Therapeutic, Inc. | Inhibitors of .alpha.v.beta.6 integrin |
| MA52117A (en) | 2017-02-28 | 2022-04-06 | Morphic Therapeutic Inc | INHIBITORS OF INTEGRIN (ALPHA-V) (BETA-6) |
| US11332498B2 (en) | 2017-03-17 | 2022-05-17 | Technische Universitat Munchen | Ligands for integrin αVβ8, synthesis and uses thereof |
| GB201706472D0 (en) * | 2017-04-24 | 2017-06-07 | Cancer Res Tech Ltd | Tumour-targeting peptide variants |
| WO2020047239A1 (en) | 2018-08-29 | 2020-03-05 | Morphic Therapeutic, Inc. | INHIBITING αV β6 INTEGRIN |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4472305A (en) | 1983-05-17 | 1984-09-18 | Sterling Drug Inc. | Hexapeptide amides |
| DE4310643A1 (en) | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Cyclic adhesion inhibitors |
| DE19538741A1 (en) | 1995-10-18 | 1997-04-24 | Merck Patent Gmbh | Cyclopeptide derivatives |
| BR9916323A (en) * | 1998-12-19 | 2001-10-30 | Merck Patent Gmbh | Integrin inhibitors alfavbeta6 |
-
1999
- 1999-07-15 DE DE19933173A patent/DE19933173A1/en not_active Withdrawn
-
2000
- 2000-07-03 PL PL00354363A patent/PL354363A1/en unknown
- 2000-07-03 WO PCT/EP2000/006188 patent/WO2001005810A2/en active IP Right Grant
- 2000-07-03 EP EP06019918A patent/EP1754714A1/en not_active Withdrawn
- 2000-07-03 EP EP00943971A patent/EP1196433B1/en not_active Expired - Lifetime
- 2000-07-03 MX MXPA02000465A patent/MXPA02000465A/en unknown
- 2000-07-03 AU AU58236/00A patent/AU772782C/en not_active Ceased
- 2000-07-03 DK DK00943971T patent/DK1196433T3/en active
- 2000-07-03 CZ CZ200226A patent/CZ200226A3/en unknown
- 2000-07-03 AT AT00943971T patent/ATE340803T1/en not_active IP Right Cessation
- 2000-07-03 CN CN00810415A patent/CN1361792A/en active Pending
- 2000-07-03 PT PT00943971T patent/PT1196433E/en unknown
- 2000-07-03 SK SK26-2002A patent/SK262002A3/en unknown
- 2000-07-03 HU HU0201925A patent/HUP0201925A3/en unknown
- 2000-07-03 DE DE50013525T patent/DE50013525D1/en not_active Expired - Fee Related
- 2000-07-03 JP JP2001511467A patent/JP2003505395A/en active Pending
- 2000-07-03 BR BR0012418-4A patent/BR0012418A/en not_active Application Discontinuation
- 2000-07-03 KR KR1020017015995A patent/KR20020010928A/en not_active Application Discontinuation
- 2000-07-03 CA CA002379022A patent/CA2379022A1/en not_active Abandoned
- 2000-07-03 ES ES00943971T patent/ES2273703T3/en not_active Expired - Lifetime
- 2000-07-13 TW TW089113997A patent/TWI226890B/en not_active IP Right Cessation
- 2000-07-14 AR ARP000103621A patent/AR024742A1/en unknown
-
2002
- 2002-01-14 NO NO20020176A patent/NO20020176D0/en unknown
- 2002-02-14 ZA ZA200201275A patent/ZA200201275B/en unknown
-
2003
- 2003-01-15 HK HK03100378.9A patent/HK1048641A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1048641A1 (en) | 2003-04-11 |
| CZ200226A3 (en) | 2002-04-17 |
| EP1754714A1 (en) | 2007-02-21 |
| EP1196433B1 (en) | 2006-09-27 |
| AR024742A1 (en) | 2002-10-23 |
| ATE340803T1 (en) | 2006-10-15 |
| KR20020010928A (en) | 2002-02-06 |
| WO2001005810A3 (en) | 2001-05-17 |
| HUP0201925A2 (en) | 2002-10-28 |
| ES2273703T3 (en) | 2007-05-16 |
| DE50013525D1 (en) | 2006-11-09 |
| ZA200201275B (en) | 2003-08-22 |
| DE19933173A1 (en) | 2001-01-18 |
| HUP0201925A3 (en) | 2002-11-28 |
| SK262002A3 (en) | 2002-07-02 |
| CA2379022A1 (en) | 2001-01-25 |
| AU5823600A (en) | 2001-02-05 |
| PL354363A1 (en) | 2004-01-12 |
| WO2001005810A2 (en) | 2001-01-25 |
| AU772782B2 (en) | 2004-05-06 |
| JP2003505395A (en) | 2003-02-12 |
| NO20020176L (en) | 2002-01-14 |
| AU772782C (en) | 2005-01-27 |
| NO20020176D0 (en) | 2002-01-14 |
| PT1196433E (en) | 2007-01-31 |
| MXPA02000465A (en) | 2002-07-30 |
| CN1361792A (en) | 2002-07-31 |
| EP1196433A2 (en) | 2002-04-17 |
| TWI226890B (en) | 2005-01-21 |
| BR0012418A (en) | 2002-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1244647T3 (en) | Quinzoline derivatives as VIGF inhibitors | |
| NO20005084D0 (en) | Heterocyclic glycyl <beta> -alanine derivatives as vitronectin antagonists | |
| NO20026252D0 (en) | AZA Bridge - Bicyclic amino acid derivatives as alpha 4 integrin antagonists | |
| DK1196433T3 (en) | Cyclic peptide derivatives as inhibitors of the alpha v, beta-6 integrin | |
| NO20033269L (en) | Urea derivatives as integrin alpha-4 antagonists | |
| NO20001687D0 (en) | Benzamidine derivatives as factor Xa inhibitors | |
| DE60024631T2 (en) | Biaryl UREA DERIVATIVES | |
| NO20012701D0 (en) | Aryl- and heterocyclyl-substituted pyrimidine derivatives as anticoagulants | |
| NO20002958D0 (en) | Benzamidine derivatives as coagulation factor Xa inhibitors | |
| NO20021459L (en) | Piperazine derivatives as 5-HT1B antagonists | |
| DK1379522T3 (en) | Dihydro-benzo (b) (1,4) diazeping-2-one derivatives as MGLUR2 antagonists I | |
| DK1097127T3 (en) | Diacylhydrazine derivatives as integrin inhibitors | |
| DK1273575T3 (en) | Diazepan derivatives or salts thereof | |
| DK1178986T3 (en) | Furanone derivatives as inhibitors of cathepsin S | |
| DK1155013T3 (en) | Heyterocyclic benzenesulfonamide derivatives as bradykinin antagonists | |
| NO20015668D0 (en) | Substituted imidazothiazoles as antidepressants | |
| DK1216250T3 (en) | Thienoisoxazolyl and thienylpyrazolyl-phenoxy-substituted propyl derivatives as D4 antagonists | |
| NO20015247D0 (en) | Glycemic system inhibitors as potential antipsychotics | |
| DK1345900T3 (en) | Guanidine and amidine derivatives as factor XA inhibitors | |
| DE60224221D1 (en) | AMINOTETRALIN DERIVATIVES, ANTAGONISTS OF MUSCARIN RECEPTORS | |
| NO20020457D0 (en) | Benzamine derivatives as anticoagulants | |
| NO20015237L (en) | Integrin antagonists | |
| TR200002831A3 (en) | Quinolin-4-Il derivatives I | |
| ATE293126T1 (en) | CYCLIC HEXAPEPTIDE DERIVATIVES | |
| NO996244D0 (en) | Pyrrolidinecarboxylic acid derivatives as endothelin antagonists |